<DOC>
	<DOCNO>NCT02334787</DOCNO>
	<brief_summary>To assess safety ( especially skin finding ) pharmacokinetics apply 0.3 % , 1 % , 3 % formulation 5g OPA-15406 ointment 1000 cm2 area single-dose multiple-dose twice daily 2 week Japanese healthy adult male subject .</brief_summary>
	<brief_title>A Phase 1 Trial OPA-15406 Ointment Healthy Adult Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>BMI = Body weight ( kg ) / [ Height ( ) ] 2 : least 18.5 less 25.0 Judged investigator subinvestigator healthy base test result screen prior administration Day 1 treatment period Findings ( sunburn , abrasion , tattoo , etc ) back affect evaluation safety skin Judged investigator subinvestigator inappropriate participate trial reason</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>